These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 18372147

  • 1. Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score.
    Ihnat DM, Duong ST, Taylor ZC, Leon LR, Mills JL, Goshima KR, Echeverri JA, Arslan B.
    J Vasc Surg; 2008 May; 47(5):967-74. PubMed ID: 18372147
    [Abstract] [Full Text] [Related]

  • 2. Primary stenting of the superficial femoral and popliteal artery.
    Dearing DD, Patel KR, Compoginis JM, Kamel MA, Weaver FA, Katz SG.
    J Vasc Surg; 2009 Sep; 50(3):542-7. PubMed ID: 19540706
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Percutaneous superficial femoral artery interventions for claudication--does runoff matter?
    Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB.
    Ann Vasc Surg; 2008 Nov; 22(6):790-8. PubMed ID: 18640817
    [Abstract] [Full Text] [Related]

  • 5. Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss.
    Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB.
    J Vasc Surg; 2008 Sep; 48(3):619-25; discussion 625-6. PubMed ID: 18727964
    [Abstract] [Full Text] [Related]

  • 6. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.
    Kawamura Y, Ishii H, Aoyama T, Tanaka M, Takahashi H, Kumada Y, Toriyama T, Murohara T.
    J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527
    [Abstract] [Full Text] [Related]

  • 7. Results for primary bypass versus primary angioplasty/stent for intermittent claudication due to superficial femoral artery occlusive disease.
    Siracuse JJ, Giles KA, Pomposelli FB, Hamdan AD, Wyers MC, Chaikof EL, Nedeau AE, Schermerhorn ML.
    J Vasc Surg; 2012 Apr; 55(4):1001-7. PubMed ID: 22301210
    [Abstract] [Full Text] [Related]

  • 8. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
    Tran K, Ullery BW, Kret MR, Lee JT.
    Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
    [Abstract] [Full Text] [Related]

  • 9. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K, Gable D, Hohman S, Pearl G, Theune B.
    J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
    [Abstract] [Full Text] [Related]

  • 10. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF, Mezzetto L, Macrì M, Criscenti P, Corvasce A, Poli R.
    Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
    [Abstract] [Full Text] [Related]

  • 11. The association of statin therapy with the primary patency of femoral and popliteal artery stents.
    de Grijs D, Teixeira P, Katz S.
    J Vasc Surg; 2018 May; 67(5):1472-1479. PubMed ID: 29224939
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical outcomes and implications of failed infrainguinal endovascular stents.
    Gur I, Lee W, Akopian G, Rowe VL, Weaver FA, Katz SG.
    J Vasc Surg; 2011 Mar; 53(3):658-66; discussion 667. PubMed ID: 21257284
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Selective stenting in subintimal angioplasty: analysis of primary stent outcomes.
    Schmieder GC, Richardson AI, Scott EC, Stokes GK, Meier GH, Panneton JM.
    J Vasc Surg; 2008 Nov; 48(5):1175-80; discussion 1180-1. PubMed ID: 18778911
    [Abstract] [Full Text] [Related]

  • 16. Below-knee bare nitinol stent placement in high-risk patients with critical limb ischaemia and unlimited supragenicular inflow as treatment of choice.
    Donas KP, Schwindt A, Schönefeld T, Tessarek J, Torsello G.
    Eur J Vasc Endovasc Surg; 2009 Jun; 37(6):688-93. PubMed ID: 19328021
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Analysis of endovascular therapy for femoropopliteal disease with the Supera stent.
    Montero-Baker M, Ziomek GJ, Leon L, Gonzales A, Dieter RS, Gadd CL, Pacanowski JP.
    J Vasc Surg; 2016 Oct; 64(4):1002-8. PubMed ID: 27444365
    [Abstract] [Full Text] [Related]

  • 19. Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force.
    Goltz JP, Ritter CO, Kellersmann R, Klein D, Hahn D, Kickuth R.
    J Endovasc Ther; 2012 Jun; 19(3):450-6. PubMed ID: 22788900
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.